Skip to main content

Table 1 Clinicopathologic features of the 122 patients with PDAC

From: Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma

ParametersPatients with PDAC (n = 122)
Median age (range)69 (43–90)
Sex
 Male/female65/57
Tumor location
 Head/body and tail71/51
Differentiation grade
 G1/G2/G3/G454/52/15/1
TNM stage
 I/II/III/IV48/50/19/5
Tumor size
 pT1/pT2/pT3/pT424/80/18/0
Microvascular invasion
 Positive/negative/unknown106/14/2
Lymphatic permeation
 Positive/negative90/32
Perineural invasion
 Positive/negative102/20
Nodal metastasis
 pN0/pN1/pN249/52/21
Neoadjuvant chemotherapy
 Yes/no65/57
Adjuvant chemotherapy
 Yes/no/unknown106/12/4
Postoperative radiotherapy
 Yes/no7/115
  1. PDAC pancreatic ductal adenocarcinoma, G1 well-differentiated carcinoma, G2 moderately differentiated carcinoma, G3 poorly differentiated carcinoma, G4 undifferentiated carcinoma